TABLE 2

Characteristics of women belonging to the three multimorbidity-related medication profiles identified by latent class analysis

Whole population“Few multimorbidity-related medications” profile“Predominantly allergic multimorbidity-related medications” profile“Predominantly metabolic multimorbidity-related medications” profilep-value
Women4328188514191024
Sociodemographic characteristics
 Age years69.6±6.168.9±5.969.3±5.871.6±6.5<0.0001
 Educational level
  Less than high school diploma449 (10.8)185 (10.1)118 (8.7)146 (14.9)<0.0001
  High school to level 2 university2050 (49.2)822 (45.1)700 (51.5)528 (53.8)
  Level 3/4 university840 (20.2)416 (22.8)271 (19.9)153 (15.6)
  Level ≥5 university826 (19.8)402 (22.0)270 (19.9)154 (15.7)
Asthma therapeutic management
 High level of asthma maintenance therapy632 (14.6)95 (5.0)356 (25.1)181 (17.7)<0.0001
 Low level of asthma maintenance therapy620 (14.3)133 (7.1)327 (23.0)160 (15.6)
 No asthma maintenance therapy3076 (71.1)1657 (87.9)736 (51.9)683 (66.7)
Asthma characteristics
 Current asthma3023 (79.9)1119 (70.9)1098 (85.8)806 (87.3)<0.0001
 Late-onset asthma1455 (36.7)545 (31.5)517 (39.0)393 (43.3)<0.0001
 Asthma–COPD overlap863 (22.7)265 (15.9)353 (28.3)245 (27.5)<0.0001
Adverse asthma events
 Uncontrolled asthma522 (19.2)127 (12.2)214 (21.5)181 (26.7)<0.0001
 At least one asthma attack1055 (25.4)317 (17.5)438 (32.3)300 (30.6)<0.0001
 At least one asthma exacerbation446 (13.2)123 (8.8)206 (17.9)117 (14.3)<0.0001
 Total AQLQ score6.0±1.06.3±0.95.9±1.05.8±1.1<0.0001

Data are presented as n, mean±sd or n (%), unless otherwise stated. COPD: chronic obstructive pulmonary disease; AQLQ: Asthma Quality of Life Questionnaire.